Relief from irritable bowel discomfort
- Provides key enzymes for improved digestion and nutrient absorption
- Promotes healthy intestinal flora
- Clinically researched herbs and nutrients to control gastrointestinal inflammation
$46.19 — or subscribe and save 20%
Inflammatory bowel disorders (IBD) are characterized by cycles of chronic relapses and remissions, chronic inflammation of the intestinal mucosa and an abnormal gut micro-flora. Sufferers tend to be afflicted by symptoms of poor digestion including gas, bloating and abdominal pain. These disorders can involve food sensitivities to common allergens such as gluten, which is found in certain grains, and casein which is found in dairy products. Celiac Disease, a type of severe gluten intolerance, is believed to affect 1 in 200 people in the modernized world. It causes an immune response to gluten which leads to intestinal inflammation and results in a decreased ability of the body to absorb nutrients.
IBD Relief includes specialized digestive enzymes that help to prevent the intestinal inflammation related to food intolerances and chronic intestinal disorders. These include AN-peptidases which are a source of DPP-IV, which break down gluten and other problematic proteins. Anti-inflammatory and stress-relieving botanicals Boswellia serrata, ashwagandha, and ginger are also included in the formula, as well as vitamin D3 which is important for immune system regulation. The probiotic yeast Saccharomyces boulardii also helps to reduce inflammation in the gut and protect the bowel from pathogens by promoting healthy intestinal flora.
AOR’s IBD Relief provides an innovative and effective combination of ingredients to help those with food sensitivities and intestinal inflammation to manage the symptoms and prevent exacerbation of the condition.Those who have inflammatory bowel disorders such as Crohn’s, Celiac Disease or colitis will benefit from taking IBD Relief.
IBD Relief is traditionally used in Herbal medicine to help relieve digestive upset/ disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic. It contains digestive enzymes that help digest proteins as well as a probiotic that forms part of a natural healthy gut flora.
AOR™ guarantees that all ingredients have been declared on the label. Contains no nuts, peanuts, sulphites, mustard, dairy, eggs, shellfish or any animal byproduct.
Take four capsules daily or two capsules twice daily with meals of your choice, or as directed by a qualified health care practitioner.
Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), or if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents or other enzyme products, are having surgery, or if you have nausea, fever, vomiting, bloody diarrhea or severe abdominal pain. Consult a health care practitioner for prolonged use. Discontinue use and consult a health care practitioner if symptoms (e.g. digestive upset, diarrhea) occur, worsen, or persist beyond three days. Hypersensitivity/allergy has been known to occur in which case discontinue use. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. This product contains corn; do not use if you have such allergy.
- Celiac disease
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.
Non-medicinal Ingredients: Microcrystalline cellulose, potato starch, maltodextrin, tapioca and potato dextrin, sodium stearyl fumarate and sodium benzoate.
Boswellia is well known for its anti-inflammatory effects. In clinical trials, promising results were obtained in UC patients using Boswellia. All parameters studied improved with boswellia supplementation, including stool properties, rectal biopsies, blood parameters, serum iron, calcium, proteins and eosinophils. Furthermore, 82% of the patients treated with boswellia went into remission whereas only 75% of the patients receiving sulfasalazine (an anti-inflammatory drug used to treat UC) experienced a remission. Similar results have also been shown for patients with Crohn’s disease. It is not surprising that according to the latest survey, 36% of German IBD patients surveyed use boswellia as part of their treatment protocol. Animal experiments have showed that boswellia modulates some components of the immune system, thereby reducing inflammation.
Vitamin D has been shown to inhibit the induction of auto-immune diseases such as systemic lupus erythematosus, type-1 diabetes and IBD. The vitamin D receptor also appears to have a critical role in the control and response of the colon to chemical injury as has been observed in studies using the development of animal models of human autoimmune diseases including experimental inflammatory bowel disease.
A study from the University of Michigan and funded by the National Cancer Institute found that taking ginger root supplements reduced intestinal inflammation by 28%. Ginger also has an excellent safety profile.
S. boulardii is a probiotic yeast that is useful for fighting off disease-causing organisms in the intestinal tract. It is used for fighting inflammation and infection in the intestinal tract as a result of microbial imbalances. In an animal study, S. boulardiireduced the inflammation associated with irritable bowel syndrome (IBD), which suggests that Saccharomyces could play a role in reducing the symptoms of IBD. In a human study on ulcerative colitis, results indicated that it was is useful for fighting the inflammatory effects of the disease, and in some patients was even able to induce remission.
Research has shown that prolyl endopeptidases (PEPs) can reduce the antigen toxicity of gluten, by cleaving proline-rich gluten peptides. PEP cleaves the gluten peptide into two shorter peptides that are cleaved further by brush-border enzymes at the intestinal microvilli. This reduces the vulnerability to gluten induced intestinal inflammation and reduces the immune response that leads to the inflammation of the lining of the gastrointestinal tract.
Preliminary research has shown that DPP IV, one of the activities of AN-PEP, also cleaves and inactivates tumor necrosis factor alpha (TNF-α), regulating the extracellular TNF-α concentration. TNF-α is an immune messenger that promotes inflammation and plays a significant part in autoimmune disorders such as inflammatory bowel disease.